# Provectus Biopharmaceuticals, Inc.: Form 8-K, filed Jun 22, 2023

- Company: [Provectus Biopharmaceuticals, Inc.](/companies/pvct.md) (CIK 315545)
- Form: 8-K
- Filed: 2023-06-22
- Accepted by EDGAR: Jun 22, 2023, 14:33 ET
- Period: 2023-06-21
- Accession: 0001493152-23-022116
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/315545/000149315223022116/form8-k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/315545/000149315223022116/

## Items reported

- Item 5.07: Shareholder vote results

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/315545/000149315223022116/form8-k.htm

Filed Jun 22, 2023.
Source: SEC EDGAR, the filing index for accession 0001493152-23-022116. Last ingested by Listed: Nov 10, 2026, 22:51 ET. No prices; not investment advice.